Stocks
TELA Bio Projects 8% Revenue Growth for 2026, Guides Q2 at $20M
TELA Bio (TELA) forecasts at least 8% revenue growth for 2026 and guides Q2 revenue to about $20.0 million, citing early success...
#stocks 96 articles
Stocks
AudioEye Sets $12M 2026 EBITDA Target, Boosts Agentic AI Focus
AudioEye targets at least $12 million in 2026 adjusted EBITDA, driven by an extended focus on agentic AI and the April 2027...
Stocks
Hampton Financial Buys 10% Stake in Dry Bulk Shipper Icon Energy
Hampton Financial Corporation (TSXV:HFC) has acquired a 10% stake in dry bulk shipping company ICON Energy Corp. (ICON:NASDAQ), citing undervaluation and improving...
Stocks
LENZ Therapeutics Reports Q1 2026 Performance, Targets 15,000 HCPs
LENZ Therapeutics delivered Q1 2026 results consistent with expectations, achieving $1.9 million in net revenue and approximately 25,000 prescriptions. The company also...
Stocks
Shell, Toyota, HSBC Lead Global Business News
Global markets saw shifts this week with major corporations like Shell, Toyota, and HSBC making headlines amidst broader economic movements.
Stocks
S&P 500 Utilities Post Strong Earnings Beats
A significant majority of S&P 500 utility companies surpassed earnings expectations this week, with 12 out of 14 beating EPS forecasts. Revenue...
Stocks
Verizon Q1 2026 Earnings Top Estimates, Guidance Up
Verizon Communications Inc. reported strong Q1 2026 non-GAAP earnings of $1.28 per share, beating consensus. The company raised its full-year profit guidance.
Stocks
Cameco Shareholders Elect Nine Directors; All Secure Over 98% Approval
Cameco (TSX: CCO; NYSE: CCJ) shareholders have elected nine board members at their annual meeting on May 7, 2026, with each nominee...
Stocks
Recursion Projects 2028 Runway, Holds 2026 Expenses Below $390M
Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...